Santa Barbara semiconductor firm raises $11.5M
Santa Barbara-based Quintessent, a semiconductor company that specializes in heterogeneous silicon photonics and quantum dot laser technology, announced it raised $11.5 million in an oversubscribed funding round, it said in a March 14 press release. The round was led by Osage University Partners along with new investors including M Ventures. Santa Barbara-based Entrada Ventures also Read More →
Nuclear AI firm emerges from stealth in SLO

For nearly two decades, Trey Lauderdale was looking to streamline healthcare communications by having the industry adopt new technological advances to establish better clinical communication practices. Now, he is attempting to do the same in the nuclear energy space. On March 11, Lauderdale and his company, Atomic Canyon, emerged from stealth and unveiled its platform, Read More →

Santa Barbara firm’s study details benefits, challenges of AI cybersecurity

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

MannKind caps off record year with Q4 earnings beat

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Inogen closes out rough year with decreasing revenue

Goleta-based Inogen saw shares dip nearly 20% in after-hours trading Feb. 27 after the company missed analyst expectations in the fourth quarter and had an overall rough year in fiscal year 2023. Inogen, a maker of portable oxygen containers, announced on Feb. 23 after the markets closed that fourth quarter total revenue was $75.9 million, down Read More →
Updated: Thousand Oaks biotech firm emerges from stealth with $135M in funding
Editor’s note: This story was updated on Feb. 23 to include more info about the company’s lead treatment. Latigo Biotherapeutics, a Thousand Oaks-based biotech firm that was originally founded by Westlake Village BioPartners, emerged from stealth mode on Feb. 14, announcing $135 million in Series A financing. Latigo is a clinical-stage biotechnology company looking to Read More →